HOHO Biotech

HoHo Biotech offers more than just a singular hydrogen supplement. It provides a comprehensive health technology ecosystem built upon a trinity of patented technology, a physiological cycle supplementation mechanism, and an AI simulation platform. This system delivers scientifically-backed, long-term molecular-level health intervention solutions for modern consumers. I’m Benson Wang, founder of HOHO Biotech. With over 20 years in biomedical innovation and a background in neurogenetics, I focus on developing Molecular Hydrogen Capsules as a clinically proven Adjuvant to enhance Immune balance and Reduce Drug Side Effects. My mission is to make hydrogen-based precision therapies accessible to patients worldwide. HoHo Biotech was founded in 2017. The company focuses on Autoimmune Disease, Hydrogen-Based Molecular Medicine, and gut microenvironment research. In 2018, it developed a "Hydrogen Capsule", a proprietary natural coral calcium material. In 2020, it received TFDA approval, becoming a "Prescription use in Regional Hospital", based on clinical trial data. In 2022, it became a "Prescription Use in Medical Center". In 2024, Launched H2 Capsule in "Pharmacy Chains", more than 200 shops. In 2024, HoHo introduced an AI molecular simulation system and built the Molecular Intelligence Engine, combining functional material science with computational modeling. In 2025, published more than 18+ Medical Papers as evidence of the "Hydrogen Capsule" as a perfect "Adjuvant" in the Autoimmune area. Launched HydroChat, an AI assistant for personalized applications. This development led to the company’s core strategy, Gut Engineering, which uses molecular signals to regulate the intestinal environment.